|1.||Lee, Myung G: 4 articles (04/2006 - 02/2004)|
|2.||Kwon, Jong W: 4 articles (04/2006 - 02/2004)|
|3.||Bae, Soo K: 4 articles (04/2006 - 02/2004)|
|4.||Kim, Won B: 3 articles (01/2006 - 02/2004)|
|5.||Vera-Cabrera, Lucio: 2 articles (01/2008 - 12/2006)|
|6.||Ocampo-Candiani, Jorge: 2 articles (01/2008 - 12/2006)|
|7.||Welsh, Oliverio: 2 articles (01/2008 - 12/2006)|
|8.||Choi, Sung Hak: 2 articles (12/2006 - 06/2005)|
|9.||Lee, Inchul: 2 articles (04/2006 - 01/2006)|
|10.||Yoo, Moohi: 2 articles (04/2006 - 06/2005)|
01/01/2008 - "Based on these results, we used 10 and 25 mg/kg subcutaneously every 24 hr; DA-7867 was also supplied in the drinking water at a calculated dose of 25 mg/kg. As a control we utilized linezolid at 25 mg/kg, a compound active in murine and human infections, three times a day. "
12/01/2006 - "marinum isolates, the MIC90s of both DA-7867 and DA-7157 were less than 0.5 microg/ml. These results demonstrate the potential of these compounds to treat NTM infections."
06/01/2005 - "For murine infection models, DA-7867 also exhibited greater efficacy than linezolid against all isolates tested."
|2.||Acute Kidney Injury (Acute Renal Failure)
01/01/2006 - "Effects of acute renal failure on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats."
01/01/2006 - "The pharmacokinetic parameters of DA-7867 were compared after intravenous and oral administration at a dose of 10 mg/kg to control rats and rats with acute renal failure induced by uranyl nitrate (rats with U-ARF). "
|3.||Protein-Energy Malnutrition (Marasmus)
05/01/2004 - "Effects of protein-calorie malnutrition on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats."
05/01/2004 - "The pharmacokinetic parameters of DA-7867, a new oxazolidinone, were compared after intravenous and oral administration at a dose of 10 mg x kg(-1) to control rats and rats with protein-calorie malnutrition (rats with PCM). "
06/01/2005 - "Effects of diabetes mellitus induced by streptozotocin (DMIS) on the pharmacokinetics of DA-7867 were investigated after i.v. and oral administration (10mg/kg) to control Sprague-Dawley rats and DMIS rats (at 7th and 29th days after administration of streptozotocin, 45mg/kg). "
06/01/2005 - "Pharmacokinetic changes of DA-7867, a new oxazolidinone, after intravenous and oral administration to rats with short-term and long-term diabetes mellitus induced by streptozotocin."
|4.||Blood Proteins (Serum Proteins)